Docosahexaenoic acid enrichment can reduce L929 cell necrosis induced by tumor necrosis factor

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1761, Issue 4, 2006, Pages 454-462

  Kishida, Etsu ^a   Tajiri, Michiko ^a   Masuzawa, Yasuo ^a  

^a HYOGO UNIVERSITY OF TEACHER EDUCATION   (Japan)

Author keywords

Docosahexaenoic acid; L929 cell; Necrosis; Polyunsaturated fatty acid; Tumor necrosis factor

Indexed keywords

ARACHIDONIC ACID; DACTINOMYCIN; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; FLUORESCEIN ISOTHIOCYANATE; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LIPOCORTIN 5; OLEIC ACID; PHOSPHOLIPID DERIVATIVE; POLYUNSATURATED FATTY ACID; PROPIDIUM IODIDE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; FATTY ACID DESATURATION; FIBROSARCOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAINING; TUMOR CELL;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; DACTINOMYCIN; DOCOSAHEXAENOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MICE; PHOSPHOLIPIDS; PROTEIN SYNTHESIS INHIBITORS; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE;

EID: 33646823117     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2006.03.023     Document Type: Article

References (58)

1. Tracey K.J., and Cerami A. Tumor necrosis factor, other cytokines and disease. Annu. Rev. Cell Biol. 9 (1993) 317-343
2. Locksley R.M., Killeen N., and Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104 (2001) 487-501
3. Uysal K.T., Wiesbrock S.M., Marino M.W., and Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389 (1997) 610-614
4. Feldmann M., and Maini R.N. Anti-TNFα therapy of rheumatoid arthritis: what have we learned?. Annu. Rev. Immunol. 19 (2001) 163-196
5. Meng X., and Harken A.H. The interaction between Hsp70 and TNF-( expression: a novel mechanism for protection of the myocardium against post-injury depression. Shock 17 (2002) 345-353
6. Sharma R., and Anker S.D. Cytokines, apoptosis and cachexia: the potential for TNF antagonism. Int. J. Cardiol. 85 (2002) 161-171
7. Chen G., and Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science 296 (2002) 1634-1635
8. Karin M., and Lin A. NF-κB at the crossroads of life and death. Nat. Immunol. 3 (2002) 221-227
9. Gupta S. A decision between life and death during TNF-α-induced signaling. J. Clin. Immunol. 22 (2002) 185-194
10. Michea O., and Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114 (2003) 181-190
11. Leist M., and Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev., Mol. Cell Biol. 2 (2001) 589-598
12. Denecker G., Vercammen D., Declercq W., and Vandenabeele P. Apoptotic and necrotic cell death induced by death domain receptors. Cell. Mol. Life Sci. 58 (2001) 356-370
13. Faraco P.R., Ledgerwood E.C., Vandenabeele P., Prins J.B., and Bradley J.R. Tumor necrosis factor induces distinct patterns of caspase activation in WEHI-164 cells associated with apoptosis or necrosis depending on cell cycle stage. Biochem. Biophys. Res. Commun. 261 (1999) 385-392
14. Khwaja A., and Tatton L. Resistance to the cytotoxic effects of tumor necrosis factor (can be overcome by inhibition of a FADD/caspase-dependent signaling pathway. J. Biol. Chem. 274 (1999) 36817-36823
15. Ruemmele F.M., Dionne S., Levy E., and Seidman E.G. TNFα -induced IEC-6 cell apoptosis requires activation of ICE caspases whereas complete inhibition of the caspase cascade leads to necrotic cell death. Biochem. Biophys. Res. Commun. 260 (1999) 159-166
16. Li M., and Beg A.A. Induction of necrotic-like cell death by tumor necrosis factor alpha and caspase inhibitors: novel mechanism for killing virus-infected cells. J. Virol. 74 (2000) 7470-7477
17. Wilson C.A., and Browning J.L. Death of HT29 adenocarcinoma cells induced by TNF family receptor activation is caspase-independent and displays features of both apoptosis and necrosis. Cell Death Differ. 9 (2002) 1321-1333
18. Sakon S., Xue X., Takekawa M., Sasazuki T., Okazaki T., Kojima Y., Piao J.H., Yagita H., Okumura K., Doi T., and Nakano H. NF-κB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J. 22 (2003) 3898-3909
19. Berghe T.V., Kalai M., Loo G., Declercq W., and Vandenabeele P. Disruption of HSP90 function reverts tumor necrosis factor-induced necrosis to apoptosis. J. Biol. Chem. 278 (2003) 5622-5629
20. Chan F.K.-M., Shisler J., Bixby J.G., Felices M., Zheng L., Appel M., Orenstein J., Moss B., and Lenardo M.J. A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses. J. Biol. Chem. 278 (2003) 51613-51621
21. Lin Y., Choksi S., Shen H.-M., Yang Q.-F., Hur G.M., Kim Y.S., Tran J.H., Nedospasov S.A., and Liu Z. Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation. J. Biol. Chem. 279 (2004) 10822-10828
22. Ventura J.-J., Cogswell P., Flavell R.A., Baldwin Jr. A.S., and Davis R.J. JNK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species. Genes Dev. 18 (2004) 2905-2915
23. Kamata H., Honda S., Maeda S., Chang L., Hirata H., and Karin M. Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120 (2005) 649-661
24. Proskuryakov S.Y., Konoplyannikov A.G., and Gabai V.L. Necrosis: a specific form of programmed cell death?. Exp. Cell Res. 283 (2003) 1-16
25. Yuan J., Lipinski M., and Degterev A. Diversity in the mechanisms of neuronal cell death. Neuron 40 (2003) 401-413
26. Eizirik D.L., and Darville M.I. β-Cell apoptosis and defense mechanisms: Lessons from type 1 diabetes. Diabetes 50 (2001) S64-S69
27. Gill C., Mestril R., and Samali A. Losing heart: the role of apoptosis in heart disease-a novel therapeutic target?. FASEB J. 16 (2002) 135-146
28. Padanilam B.J. Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis. Am. J. Physiol.: Renal, Physiol. 284 (2003) F608-F627
29. Kaplowitz N. Biochemical and cellular mechanisms of toxic liver injury. Semin. Liver Dis. 22 (2002) 137-144
30. Kroemer G., and Martin S.J. Caspase-independent cell death. Nat. Med. 11 (2005) 725-730
31. Pettus B.J., Chalfant C.E., and Hannun Y.A. Ceramide in apoptosis: an overview and current perspectives. Biochim. Biophys. Acta 1585 (2002) 114-125
32. Fernandez-Checa J.C. Redox regulation and signaling lipids in mitochondrial apoptosis. Biochem. Biophys. Res. Commun. 304 (2003) 471-479
33. Hayakawa M., Ishida N., Takeuchi K., Shibamoto S., Hori T., Oku N., Ito F., and Tsujimoto M. Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor. J. Biol. Chem. 268 (1993) 11290-11295
34. Taketo M.M., and Sonoshita M. Phospolipase A2 and apoptosis. Biochim. Biophys. Acta 1585 (2002) 72-76
35. Cauwels A., Janssen B., Waeytens A., Cuvelier C., and Brouckaert P. Caspase inhibition causes hyperacute tumor necrosis factor-induced shock via oxidative stress and phospholipase A2. Nat. Immunol. 4 (2003) 387-393
36. Cao Y., Pearman A.T., Zimmerman G.A., McIntyre T.M., and Prescott S.M. Intracellular unesterified arachidonic acid signals apoptosis. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 11280-11285
37. Scorrano L., Penzo D., Petronilli V., Pagano F., and Bernardi P. Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-α apoptotic signaling. J. Biol. Chem. 276 (2001) 12035-12040
38. Yano M., Kishida E., Iwasaki M., Kojo S., and Masuzawa Y. Docosahexaenoic acid and vitamin E can reduce human monocytic U937 cell apoptosis induced by tumor necrosis factor. J. Nutr. 130 (2000) 1095-1101
39. Kishida E., Yano M., Kasahara M., and Masuzawa Y. Distinctive inhibitory activity of docosahexaenoic acid against sphingosine-induced apoptosis. Biochim. Biophys. Acta 1391 (1998) 401-408
40. Kim H.-Y., Akbar M., Lau A., and Edsall L. Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3). Role of phosphatidylserine in antiapoptotic effect. J. Biol. Chem. 275 (2000) 35215-35223
41. Kim H.-Y., Akbar M., and Kim K.-Y. Inhibition of neuronal apoptosis by polyunsaturated fatty acids. J. Mol. Neurosci. 16 (2001) 223-237
42. Akbar M., and Kim H.-Y. Protective effects of docosahexaenoic acid in staurosporine-induced apoptosis: involvement of phosphatidylinositol-3 kinase pathway. J. Neurochem. 82 (2002) 655-665
43. Akbar M., Calderon F., Wen Z., and Kim H.-Y. Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 10858-10863
44. Rotstein N.P., Aveldaño M.I., Barrantes F.J., Roccamo A.M., and Politi L.E. Apoptosis of retinal photoreceptors during development in vitro: protective effect of docosahexaenoic acid. J. Neurochem. 69 (1997) 504-513
45. Polit L., Rotstein N., and Carri N. Effects of docosahexaenoic acid on retinal development: cellular and molecular aspects. Lipids 36 (2001) 927-935
46. Rotstein N.P., Politi L.E., German O.L., and Girotti R. Protective effect of docosahexaenoic acid on oxidative stress-induced apoptosis of retina photoreceptors. Invest. Ophthalmol. Visual Sci. 44 (2003) 2252-2259
47. Moriguchi K., Yuri T., Yoshizawa K., Kiuchi K., Takada H., Inoue Y., Hada T., Matsumura M., and Tsubura A. Dietary docosahexaenoic acid protects against N-methyl-N-nitrosourea-induced retinal degeneration in rats. Exp. Eye Res. 77 (2003) 167-173
48. Calon F., Lim G.P., Yang F., Morihara T., Teter B., Ubeda O., Rostaing P., Triller A., Salem Jr. N., Ashe K.H., Frautschy S.A., and Cole G.M. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 43 (2004) 633-645
49. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37 (1959) 911-917
50. Berghe T.V., Denecker G., Brouckaert G., Krysko D.V., D'Herde K., and Vandenabeele P. More than one way to die. Methods to determine TNF-induced apoptosis and necrosis. In: Corti A., and Ghezzi P. (Eds). Tumor Necrosis Factor. Methods Mol. Med. vol. 98 (2004), Humana Press Inc., N.J. 101-126
51. Jump D.B. The biochemistry of n-3 polyunsaturated fatty acids. J. Biol. Chem. 277 (2002) 8755-8758
52. Hardman W.E. Omega-3 fatty acids to augment cancer therapy. J. Nutr. 132 (2002) S3508-S3512
53. Bernardi P., Penzo D., and Wojtczak L. Mitochondrial energy dissipation by fatty acids. Mechanisms and implications for cell death. Vitam. Horm. 65 (2002) 97-126
54. Goodman D.W.S. The interaction of human serum albumin with long-chain fatty acid anions. J. Am. Chem. Soc. 80 (1958) 3892-3898
55. Donovan M., and Cotter T.G. Control of mitochondrial integrity by Bcl-2 family members and caspase-independent cell death. Biochim. Biophys. Acta 1644 (2004) 133-147
56. 2+s-dependent apoptosis through the mitochondrial pathway. J. Biol. Chem. 279 (2004) 25219-25225
57. Shikano M., Masuzawa Y., Yazawa K., Takayama K., Kudo I., and Inoue K. Complete discrimination of docosahexaenoate from arachidonate by 85(kDa cytosolic phospholipase A2 during the hydrolysis of diacyl- and alkenylacylglycerophosphoethanolamine. Biochim. Biophys. Acta 1212 (1994) 211-216
58. Mochizuki T., Asai A., Saito N., Tanaka S., Katagiri H., Asano T., Nakane M., Tamura A., Kuchino Y., Kitanaka C., and Kirino T. Akt protein kinase inhibits non-apoptotic programmed cell death induced by ceramide. J. Biol. Chem. 277 (2002) 2790-2797